Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Catamaran Corp. (NASDAQ: CTRX)(TSX: CCT) shares declined 0.91 percent to close at $44.70 a share Wednesday. The stock traded between $44.35 and $45.40 on volume of 2.17 million shares traded. Analysts at Barclays have recently initiated coverage on the company with an “equal weight” rating. Shares of Catamaran have fallen approximately 6.0 percent year-to-date.
Find out more about Catamaran including full access to the free equity report at:
Energen Corporation (NYSE: EGN) shares declined 0.69 percent to close at $82.22 a share Wednesday. The stock traded between $81.72 and $83.65 on volume of 817,070 shares traded. Analysts at Maxim have recently initiated coverage on the company with a “buy” rating and a price target of $94.00. Shares of Energen have gained approximately 16.0 percent year-to-date.
Find out more about Energen including full access to the free equity report at:
Express Scripts Holding Company (NASDAQ: ESRX) shares increased 1.97 percent to close at $77.15 a share Wednesday. The stock traded between $74.86 and $77.17 on volume of 6.72 million shares traded. Analysts at Barclays have recently initiated coverage on the company with an “overweight” rating. Shares of Express Scripts have gained approximately 10.0 percent year-to-date.
Find out more about Express Scripts including full access to the free equity report at:
Pacer International, Inc. (NASDAQ: PACR) shares increased 0.06 percent to close at $9.01 a share Wednesday. The stock traded between $8.99 and $9.03 on volume of 618,187 shares traded. Analysts at Avondale have recently downgraded the company’s rating to “market perform” from “outperform”. Shares of Pacer International have gained approximately 9.0 percent year-to-date.
Find out more about Pacer International including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing